Results 1 to 10 of about 33,519 (179)

Assessment of Psychological Problems for Patients with Acute Myelogenous Leukemia

open access: yesKufa Journal for Nursing Sciences, 2015
Objective: To assess the psychological problems in patients with acute myelogenous leukemia, and to find out the relationship between socio-demographic characteristics such as (age, sex, marital status, educational level, and occupation) and ...
Kareem R. Sachitt
doaj   +3 more sources

Granulocytic Sarcoma with Compressive Myelopathy: A Rare Presentation of Chronic Myelogenous Leukemia [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Granulocytic sarcoma occurs most commonly in acute myelogenous leukemia. The appearance of granulocytic sarcoma in chronic myelogenous leukemia signals accelerated phase/ blast transformation.
Abhijeet P. Ganapule   +4 more
doaj   +1 more source

Acute myelogenous leukemia revealed by acute appendicitis

open access: yesApollo Medicine, 2020
Acute myelogenous leukemia can rarely involve the digestive tract. We report a case of a girl of 9 years old, admitted for surgical abdomen and operated for acute appendicitis. Complete blood count showed pancytopenia.
Sanae El Marzguioui   +4 more
doaj   +1 more source

Isolated hyperbilirubinemia as the manifestation of acute liver failure in a patient with acute myelogenous leukemia and COVID-19 infection

open access: yesEuropean Journal of Translational Myology, 2021
Acute liver failure is a rare but catastrophic syndrome. Liver function tests usually reveal cholestatic or hepatocellular pattern, but in this case, we report a previously undescribed manifestation of this condition as isolated hyperbilirubinemia.
Nasrin Gholami   +4 more
doaj   +1 more source

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

open access: yesHaematologica, 2015
The prognosis of older patients with acute myelogenous leukemia is generally poor. The interleukin-3 receptor α-chain (CD123) is highly expressed on the surface of acute leukemia cells compared with normal hematopoietic stem cells.
Erwin M. Lee   +12 more
doaj   +1 more source

The Treatment of Acute Myelogenous Leukemia [PDF]

open access: yes, 1987
It has recently been suggested that it is possible to cure at least 25% of younger adults who have acute myelogenous leukaemia [1], The results achieved at St. Bartholomew’s Hospital, London, demonstrate this and may be used to illustrate the still outstanding problems.
R, Bassan   +6 more
openaire   +2 more sources

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

open access: yesCase Reports in Cardiology, 2018
Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia.
Pradyumna Agasthi   +4 more
doaj   +1 more source

Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells

open access: yesHaematologica, 2014
Although farnesyltransferase inhibitors have shown promising activity in relapsed lymphoma and sporadic activity in acute myelogenous leukemia, their mechanism of cytotoxicity is incompletely understood, making development of predictive biomarkers ...
Husheng Ding   +14 more
doaj   +1 more source

Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells

open access: yesHaematologica, 2008
The α4β1 integrin very late activation antigen-4 (VLA-4) is an α4 (CD49d)/β1 (CD29) heterodimer. It plays a key role in the adhesion of both hematopoietic progenitor cells and leukemic blast cells to bone marrow stromal cells which express the vascular ...
Ulrich Mahlknecht, Christiane Schönbein
doaj   +1 more source

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

open access: yesHaematologica, 2013
Therapy-related myelodysplastic syndromes and acute myelogenous leukemia comprise a poor-risk subset of myelodysplastic syndromes and acute myelogenous leukemia.
Alan H. Shih   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy